TITLE:
Preeclampsia in Multiparous Women: Epidemiological and Clinical Profile and Maternal-Fetal Prognosis
AUTHORS:
Amadou Bocoum, Soumana Oumar Traoré, Mamadou Sima, Seydou Fané, Abdoulaye Sissoko, Aminata Kouma, Ibrahim Ousmane Kanté, Siaka Amara Sanogo, Cheickna Sylla, Aminata Bathily, Youssouf Traoré, Ibrahima Teguete, Niani Mounkoro
KEYWORDS:
Preeclampsia, Multiparous Women, Management, Prognosis, G. Touré University Hospital, Mali
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.15 No.11,
November
25,
2025
ABSTRACT: Introduction: Preeclampsia (PE) is a serious pregnancy complication responsible for numerous maternal and fetal issues and remains a global public health concern. It primarily affects first-time mothers, but its impact on women who have given birth before is often less studied. This study aims to analyze the epidemiological and clinical characteristics of preeclampsia in women who have given birth before and to assess the associated maternal and fetal risks. Methodology: This was a cross-sectional study conducted at the Gabriel Touré University Hospital in Bamako over 12 months (January 1-December 31, 2022). The study included all patients presenting with pre-eclampsia, divided into three groups according to parity: primiparous, pauciparous, and multiparous. Data were collected from medical records and analyzed using IBM SPSS software with appropriate statistical tests. Results: Among 4225 admissions, 858 cases of preeclampsia were identified, with a prevalence of 19.99%. The incidence of preeclampsia in multiparous women was 37.72%. The most frequent clinical signs included headaches (38.1% in primiparous women vs. 37% in multiparous women), epigastric pain, and visual disturbances. The most common maternal complications were eclampsia (52.1%), followed by refractory hypertension of the mother (32.5%). The maternal mortality rate was 5.6%, while 72% of newborns had a birth weight less than 2500 g. Conclusion: Preeclampsia has severe consequences for maternal and fetal prognosis, particularly in multiparous women, where the risks of complications such as eclampsia and refractory hypertension are more frequent.